Skip to main content
Premium Trial:

Request an Annual Quote

Edmond Fischer Dies

Edmond Fischer, who won the 1992 Nobel Prize in Physiology or Medicine for his work on reversible protein phosphorylation, has died, the Washington Post reports. He was 101.

Fischer won the prize jointly with his University of Washington colleague Edwin Krebs, who died in 2009. As the Post notes, Fischer and Krebs were interested in the enzymes involved in muscle contraction and by focusing on phosphorylase with its different active and inactive forms, uncovered the process of reversible protein phosphorylation. This, the New York Times adds, "turned out to be one of the fundamental mechanisms of cell signaling."

It is also important for the understanding of diseases like Alzheimer's disease, diabetes, and some types of cancer as well as in the development of drugs, including ones to prevent organ transplant rejections, the Post notes.

"The beauty of science is that you know where you start from, but you never know where you will end up," Fischer said in a 2020 interview with the Lindau Nobel Laureate Meetings, according to the Times.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.